The Swedish medical technology firm, Nobel Biocare, has become the newest company to launch itself on the Swiss stock exchange (SWX).
On Monday, the company's shares were launched simultaneously on both the Zurich and Stockholm bourses.
The company share price, which stood at SFr100 when the SWX opened for business on Monday, rose to SFr102 within the first half hour of trading.
Nobel Biocare, whose core business is focused on the manufacture of dental implants and prosthetics, said the simultaneous launch would "increase the company's visibility in all markets."
"We welcome this opportunity also to attract new shareholders," commented company CEO, Heliane Canepa.
Nobel Biocare - currently the world number one in dental implants with a global workforce of around 1300 employees - has its headquarters in Gothenburg, Sweden, with additional production centres in both Sweden and the USA.
The company, which in 2001 reported an annual turnover of SFr425 million, is the main rival to the Basel-based dental implants firm, Straumann, which itself reported sales of SFr232 million last year.
swissinfo with agencies